Summary of results B: Participants with at least one adverse event | |||||
Dose | Studies | Participants | Etodolac (%) | Placebo (%) | NNH (95%CI) |
50 mg | 4 | 320 | 8 | 6 | not calculated |
100 mg | 5 | 459 | 11 | 7 | not calculated |
200 mg | 7 | 633 | 22 | 17 | not calculated |
400 mg | 4 | 310 | 28 | 34 | not calculated |